Fungal pericarditis is a rare disease but its incidence has risen in parallel with the global increase in invasive fungal infections. This systematic review analyzes data from previously reported cases of fungal pericarditis to provide an improved understanding of the etiology, clinical presentation, management, and outcomes of this rare disease. We reviewed Medline and Scopus databases from 1 January 1990 to 29 January 2024 for case reports that documented the isolation of a fungal pathogen from pericardial fluid or tissue. Of the 2330 articles screened, 101 cases met the inclusion criteria. Patients with fungal pericarditis and the involvement of at least one other organ—usually the lungs, brain, or kidney—had worse outcomes than patients with isolated pericardial disease. Immunosuppression was reported in 50% of cases and was associated with worse outcomes in adults. Patients who presented with chest pain, received adequate empiric antifungal therapy, and underwent pericardiocentesis and pericardiectomy had improved survival. The most common isolated pathogens were Candida spp., followed by Aspergillus spp. and Mucor spp., with the latter two linked to worse outcomes. Only 35% of patients received empiric antifungal medications before the causative pathogen was identified, and mortality was associated with a delay in appropriate therapy. Immunosuppression, disseminated disease, and presence of shock/multiorgan failure were additional risk factors associated with death. Fungal pericarditis carries a mortality rate of up to 50%, with nearly half of patients being immunocompromised. Clinicians frequently do not consider fungal pericarditis in the differential diagnoses, which leads to delays in treatment and poorer outcomes. Further prospective multicenter studies are urgently needed to better understand the epidemiology, improve diagnostic testing and management, and decrease unacceptably high mortality in patients with fungal pericarditis.
In 1885, French neuropsychiatrist Dr. Georges Gilles de la Tourette was the first to describe a disease of tics. His success was not unexpected, as he was a student of the renowned neurologist Dr. Jean-Martin Charcot. Georges Gilles de la Tourette was born on October 30, 1857, in Saint-Gervais-les-Trois-Clochers, France, as the eldest of four children. Immediately after graduating in 1881, he went to Paris for further training. His special interests included hysteria, psychotherapy, and hypnotism. By revising an article titled “Experiments with the ‘Jumpers of Maine’ ”, he concluded that a somewhat similar disorder exists in different cultures across the world. He soon described additional signs of the syndrome, including inarticulate sounds, echolalia, and coprolalia, and accentuated the hereditary nature of the disease. Insightful and dedicated yet short-tempered and arrogant, Georges Gilles de la Tourette was an inspiring physician and teacher. He left behind a significant legacy in the study of involuntary movements, particularly through his description of the syndrome that would come to be known as Tourette syndrome. This description of the syndrome is just a portion of his contributions to neurology and psychiatry. His work, often met with both admiration and criticism, reflects the complexities of his personality and the challenges he faced in his professional life.
1 January 2026 in Pediatric Gastroenterology, Hepatology & Nutrition
Coronary microvascular dysfunction (CMD) is an important cause of angina and myocardial ischemia in patients without obstructive coronary artery disease and contributes substantially to the clinical spectrum of angina with non-obstructive coronary arteries (ANOCA) and ischemia with non-obstructive coronary arteries (INOCA). These conditions represent a heterogeneous group of coronary vasomotor disorders in which structural and functional abnormalities of the coronary microcirculation, endothelial dysfunction, coronary vasospasm, and diffuse non-obstructive atherosclerosis may occur alone or in combination. This review summarizes current knowledge on the pathophysiology, diagnosis, and management of CMD in patients with ANOCA and INOCA. We discuss the distinction between ANOCA and INOCA, the principal coronary functional endotypes, and the mechanisms responsible for impaired coronary microvascular function. We also review contemporary diagnostic approaches, including non-invasive imaging and invasive coronary function testing, with emphasis on their complementary roles in identifying the underlying mechanism of ischemia. Current management strategies are presented from a mechanism-based perspective, including lifestyle modification, pharmacological therapy, endotype-guided treatment, and emerging therapeutic approaches. Improved understanding of coronary functional abnormalities has shifted clinical evaluation beyond the exclusion of obstructive coronary artery disease toward identification of the mechanism responsible for persistent symptoms and ischemia. Continued advances in disease phenotyping, coronary function testing, and targeted therapies are expected to support more individualized management and improve outcomes in this diverse patient population.
Babesiosis is a tick-borne infection caused by intraerythrocytic Babesia parasites and may result in severe hemolytic anemia and systemic complications. Coinfection with other Ixodes-borne pathogens may further complicate diagnosis and management. We report a 45-year-old immunocompetent man working as a landscaper in Connecticut who presented with syncope following two weeks of fever, fatigue, diaphoresis, arthralgias, jaundice, and dark urine. Laboratory evaluation revealed profound hemolytic anemia with a hemoglobin of 6.8 g/dL, elevated lactate dehydrogenase (LDH), undetectable haptoglobin, reticulocytosis, and stage 1 acute kidney injury. Peripheral blood smear demonstrated characteristic Maltese cross formations, with approximately 0.6% parasitemia, and polymerase chain reaction (PCR) testing confirmed Babesia microti and Borrelia burgdorferi coinfection. Direct antiglobulin testing for immunoglobulin G (IgG) was negative. The patient required intensive care monitoring and transfusion and improved following treatment with atovaquone, azithromycin, and doxycycline. Subsequent outpatient evaluation identified asymptomatic Strongyloides stercoralis infection, which was treated with ivermectin. This finding was clinically significant because warm autoimmune hemolytic anemia is a recognized complication of babesiosis and may require corticosteroid therapy, which can precipitate potentially life-threatening Strongyloides hyperinfection in patients with occult infection. This case highlights that severe babesiosis may occur despite low-level parasitemia and emphasizes the importance of recognizing coinfections and obtaining a detailed occupational and environmental exposure history, particularly when future immunosuppressive therapy may be considered.
1 January 2023 in Srpski arhiv za celokupno lekarstvo
Introduction. Acute myocarditis is a serious inflammatory condition of the myocardium. Clinically, symptoms may differ from case to case, and as such can pose a significant diagnostic dilemma. Here we present a case of acute focal myocarditis with markedly elevated troponins, in which diagnosis was finally made using cardiac magnetic resonance (CMR). Case outline. A male patient, 26-year-old, without cardiovascular risk factors presented with severe chest pain, diaphoresis, pallor, and dyspnea. Blood pressure was 160/110 mmHg, and ECG showed ST-segment elevation in inferior leads. In laboratory there was an extreme elevation of Troponin. Inferior-posterior-lateral STEMI was suspected, and initial treatment was given according to that suspicion. The patient was then sent to catheterization laboratory for further evaluation, which showed absence of coronary artery disease. A working diagnosis of myocardial infarction with non-obstructive coronary arteries (MINOCA) was established. To distinguish MINOCA from other causes of myocardial injury with elevated troponins, a CMR was done, and its finding was consistent with focal myocarditis of inferolateral localization. Further treatment consisted of beta blockers, ACE inhibitors and avoidance of strenuous activity for the next six months. The patient fully recovered and had no further complications with ECG only showing flat T-wave in D3 lead. Conclusion. Focal myocarditis is an unusual manifestation of myocardial disease and can confuse physicians, especially if it occurs along with elevated cardiac markers and ST-elevation, but in a young patient, without any known comorbidity, this diagnosis must be considered. Here, a cardiovascular magnetic resonance may be a useful tool.